Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 20, 2009Journal of Enzyme Inhibition and Medicinal ChemistryOpen Access

Design, synthesis and evaluation of 3-(imidazol- 1-ylmethyl)indoles as antileishmanial agents. Part II

View Full Paper
Ask AI
Bookmark
Share

Authors

FGF GiraudCLCédric LogéFPFabrice Pagniez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Giraud et al. (2009) studied this question.

synapsesocial.com/papers/6a9e32f30bfbee156fd6f152https://doi.org/10.1080/14756360802610795
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis and Antileishmanial Activity of 3-Imidazolylalkylindoles. Part I2004 · 7 citations
  2. 2Imidazole Transfer from 1,1‘-Carbonyldimidazole and 1,1‘-(Thiocarbonyl)diimidazole to Alcohols. A New Protocol for the Conversion of Alcohols to Alkylheterocycles1997 · 30 citations
  3. 3Treatment of cutaneous leishmaniasis among travellers2004 · 262 citations
  4. 4Synthesis and reactions of 5-bromoskatole and 5-bromo-1,3-dimethylindole1967 · 31 citations
  5. 5Interactions of the ergosterol biosynthetic pathway with other lipid pathways2005 · 38 citations